SMAD7 antibody (AA 88-135) (Cy3)
Quick Overview for SMAD7 antibody (AA 88-135) (Cy3) (ABIN8038214)
Target
See all SMAD7 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 88-135
-
Purpose
- Anti-MADH7/SMAD7 Antibody Cy3 Conjugated
-
Cross-Reactivity (Details)
- No cross-reactivity with other proteins.
-
Purification
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human MADH7/SMAD7 recombinant protein (Position: A88-R135).
-
Isotype
- IgG
-
-
-
-
Application Notes
- Flow Cytometry, 1-3 μg/1x106 cells
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Expiry Date
- 12 months
-
-
- SMAD7 (SMAD, Mothers Against DPP Homolog 7 (SMAD7))
-
Alternative Name
- SMAD7
-
Background
-
Background: Mothers against decapentaplegic homolog 7 or SMAD7 is a protein that in humans is encoded by the SMAD7 gene. The protein encoded by this gene is a nuclear protein that binds the E3 ubiquitin ligase SMURF2. Upon binding, this complex translocates to the cytoplasm, where it interacts with TGF-beta receptor type-1 (TGFBR1), leading to the degradation of both the encoded protein and TGFBR1. Expression of this gene is induced by TGFBR1. Variations in this gene are a cause of susceptibility to colorectal cancer type 3 (CRCS3). Several transcript variants encoding different isoforms have been found for this gene.
Gene Full Name: SMAD family member 7
-
Gene ID
- 4092
-
UniProt
- O15105
-
Pathways
- Interferon-gamma Pathway, Cell-Cell Junction Organization
Target
-